Put the body on offense.

• Skip to Content
• For Patients
• For Physicians
• About PhosChol
• Areas of Use
• Why PhosChol?
• Talk to Your Physician
• FAQs
• Ask the Experts
• Request a Brochure
• Reference Library
• Community
• Order PhosChol
• Contact Us
• Newsroom

Reference Library Articles

Polyunsaturated phospholipids increase the hypolipidemic effect of Lovastatin (2005-07-12) [PDF]
Author: Dr. K.-J. Gundermann
In this double-blind trial, the combined therapy of EPL with a low-dose of Lovastatin effectively decreased LDL-cholesterol. Furthermore, EPL reduced the ALT activity as well as spontaneous and induced platelet aggregation which were increased after longterm Lovastatin therapy.

To view study details and results, click on the pdf link above.

Return to Search Results

PhosChol is a DIETARY SUPPLEMENT: These statements have not been evaluated by the Food and Drug Administration. PhosChol is not intended to diagnose, treat, cure or prevent any disease. (Read Full Disclaimer)

MEDICAL DISCLAIMER: All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. We cannot and do not give medical advice. (Read Full Disclaimer)